Androgen deprivation therapy for prostate cancer and the risk of thyroid diseases.
Jui-Ming LiuYu-Tang ChenChun-Te WuWen-Lin HsuRen-Jun HsuPublished in: The Prostate (2022)
The result showed that ADT use in men with PCa was associated with a decreased risk of thyroid disease development.